610 BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN INFLAMMATORY BOWEL DISEASE (IBD): REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT
Gastroenterology（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要